Ketamine for Depression
1123 providers treating depression
Providers experienced in treating depression with ketamine therapy, including treatment-resistant depression (TRD) and major depressive disorder (MDD).
Ketamine Therapy for Depression
If you have treatment-resistant depression (TRD), meaning you have tried two or more antidepressants without adequate relief, ketamine therapy may be worth considering. Research over the past two decades has established ketamine as one of the more significant developments in depression treatment, particularly for people who have not responded to conventional medications. TRD affects roughly one-third of people diagnosed with major depressive disorder, so this is not a rare situation.
Unlike traditional antidepressants that can take weeks to show effects, ketamine often produces noticeable changes within hours to days. Clinical studies consistently report response rates of 60-70% in patients with TRD, which is notable given that this population has already failed multiple standard treatments. Response is typically measured as a 50% or greater reduction in depression severity scores. Remission rates, meaning near-complete symptom resolution, are lower but still meaningful at around 30-40%.
A standard treatment protocol usually involves a series of six infusions over two to three weeks, followed by maintenance sessions as needed. Some clinics offer intramuscular injections or the FDA-approved nasal spray esketamine (Spravato) as alternatives to IV infusion. The choice of delivery method depends on your provider's assessment, your insurance situation, and practical considerations like clinic access. Each IV session typically lasts about 40 minutes, with an additional monitoring period of 30-60 minutes afterward.
The effects of a single infusion are temporary, generally lasting days to a couple of weeks. This is why an initial series is recommended, and most people require some form of ongoing treatment to sustain benefits. Your provider should work with you to find the minimum effective frequency for maintenance sessions, which varies considerably from person to person. Some people do well with monthly infusions, while others need them more frequently.
Ketamine therapy for depression is not a standalone solution for most people. It works best as part of a broader treatment plan that may include psychotherapy, lifestyle changes, and in some cases continued use of other medications. The rapid onset of ketamine's effects can provide a window of relief that makes it easier to engage with these other interventions, which is one of its most practical benefits.
How Ketamine Treats Depression
Ketamine works primarily on the brain's glutamate system, which is distinct from the serotonin and norepinephrine pathways targeted by most antidepressants. By blocking NMDA receptors, ketamine triggers a cascade that increases brain-derived neurotrophic factor (BDNF) and activates mTOR signaling, which promotes the rapid formation of new synaptic connections in brain regions affected by depression, particularly the prefrontal cortex and hippocampus.
This mechanism of synaptic plasticity is thought to explain why ketamine can produce effects so much faster than SSRIs or SNRIs. Rather than gradually shifting neurotransmitter levels over weeks, ketamine essentially helps the brain rebuild neural pathways that have been weakened by chronic depression. Brain imaging studies have confirmed that people with depression often show reduced synaptic density in the prefrontal cortex, and ketamine appears to partially reverse this deficit within hours.
Who Is a Candidate?
You may be a candidate for ketamine therapy if you have been diagnosed with major depressive disorder and have not responded adequately to at least two antidepressant trials at appropriate doses and durations. Your provider will also evaluate whether you have any conditions that could make ketamine risky, such as uncontrolled hypertension, active substance use disorders, or a history of psychosis.
Ketamine is generally considered after, not instead of, first-line treatments. If you are early in your treatment journey, your provider will likely recommend trying standard options first.
Frequently Asked Questions
- Many people notice some improvement within hours of their first infusion, though the full effect typically builds over the initial series of treatments. This rapid onset is one of the key differences from traditional antidepressants, which generally require four to six weeks to take effect.
- A single infusion typically provides relief lasting a few days to two weeks. An initial series of six infusions tends to produce longer-lasting effects. Most people need maintenance infusions at intervals ranging from every two weeks to every couple of months to sustain the benefits.
- You should not stop any medications without your prescriber's guidance. Many providers recommend continuing your current antidepressants alongside ketamine therapy. Some evidence suggests that concurrent antidepressant use may actually help prolong ketamine's effects. Any medication changes should be made gradually and under supervision.